Cypress Capital Management (Wyoming)’s iShares Biotechnology ETF IBB Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-25	Closed	-$2K	–	190
2019 Q3	$2K	Sell	25 -250	-91%	-$26.2K	﹤0.01%	182
2019 Q2	$30K	Hold	275	–	–	0.04%	140
2019 Q1	$31K	Hold	275	–	–	0.04%	135
2018 Q4	$27K	Sell	275 -100	-27%	-$10.6K	0.05%	163
2018 Q3	$46K	Buy	375 +25	+7%	+$2.94K	0.05%	174
2018 Q2	$38K	Hold	350	–	–	0.04%	177
2018 Q1	$37K	Buy	+350	New	+$38.8K	0.04%	162

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s IBB Position: Q4 2019 in Review

Cypress Capital Management (Wyoming) sold out of iShares Biotechnology ETF (IBB) in Q4 2019, closing a stake of 25 shares — an estimated $2K sold.

Cypress Capital Management (Wyoming) first reported a position in IBB in Q1 2018 and held it in 7 quarters. The position peaked at $46K in Q3 2018. 710 funds tracked by Wall St. Rank hold IBB as of Q4 2019.

Cypress Capital Management (Wyoming) reported no remaining iShares Biotechnology ETF position as of Q4 2019 after selling out during the quarter.
Cypress Capital Management (Wyoming) sold 25 iShares Biotechnology ETF shares in Q4 2019, an estimated $2K.
Cypress Capital Management (Wyoming) first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 7 quarters.
Cypress Capital Management (Wyoming)'s iShares Biotechnology ETF position peaked at $46K in Q3 2018.
710 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2019.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q4 2019, filed 3 Feb 2020.